Qube Research & Technologies LTD Rezolute, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$2.73 - $5.57 $22,631 - $46,175	8,290 Added 2.69%	315,900 $916,000
Q4 2024 Feb 14, 2025	BUY	$4.08 - $5.96 $737,031 - $1.08 Million	180,645 Added 142.28%	307,610 $1.47 Million
Q3 2024 Nov 14, 2024	BUY	$4.13 - $5.31 $519,281 - $667,647	125,734 Added 10213.97%	126,965 $615,000
Q2 2024 Aug 14, 2024	BUY	$2.29 - $5.79 $2,814 - $7,115	1,229 Added 61450.0%	1,231 $5,000
Q3 2023 Nov 13, 2023	BUY	$1.32 - $2.1 $2 - $4	2 New	2 $0

124

68.9M

1.01M

57.2K

Ticker RZLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,600
Market Cap $385M
Description
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.